Curasight investor relations material
Listen to the latest call from Curasight
Curasight is a clinical stage biopharmaceutical company dedicated to developing uPAR Theranostics for the early detection, diagnosis and treatment of cancer. The company's mission is to make a global impact by harnessing imaging technology that improves diagnosis and correlates to improved long-term patient outcome.
Ticker
CURASCountry
DKAbout
IR-page